Navigation Links
BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
Date:2/26/2008

INDIANAPOLIS, Feb. 26 /PRNewswire/ -- BioStorage Technologies, Inc. (BST), announces the appointment of Dr. Wolfgang Hoffer as Managing Director of the company's European operations in Griesheim, Germany. Hoffer joins BST with nearly 20 years of management experience in the fields of clinical pharmacology and toxicology. In his new role, Hoffer will report directly to James M. Saponaro, Chief Operating Officer for BST, and will manage all aspects of BST's Europe Division, including sales and marketing, operations and finance.

Dr. Hoffer has previously held positions with MOMENTUM Pharma Services, MDS Pharma Services, PAREXEL(R) International, The Boston Consulting Group and Solvay Pharma. Most recently, he was site director of MOMENTUM Pharma Services' Hamburg, Germany, location, following its spinout from MDS Pharma Services.

"Hoffer will focus on offering worldwide service to our global pharmaceutical clients while maintaining our standards of operational excellence," said F. John Mills, M.D., Ph.D., Chief Executive Officer and Chairman of the Board.

"We were looking for someone with broad, credible experience in the pharmaceutical and contract research industry. Not only does Wolfgang have the right level of industry experience and credentials, but he also has a first- rate, entrepreneurial spirit. We wanted someone who is willing to roll up his sleeves and get things done, and he is definitely that kind of individual," said Mills.

Dr. Hoffer holds a doctorate in physiological chemistry from the University of Veterinary Medicine Hannover (Germany), and is a certified veterinarian in the German state of Bavaria. Dr. Hoffer began his educational career studying chemistry and biology at the University of Kaiserslautern (Germany).

About BioStorage Technologies, Inc.:

BioStorage Technologies, Inc. is a worldwide leader in sample storage, inventory management and cold-chain logistics for the biotechnology and pharmaceutical industries throughout the research, clinical trial and commercialization phases of drug development. The company offers secure, temperature-controlled storage; real-time tracking of stored biological samples; and next-day return of biomaterials. BioStorage Technologies is privately-held and headquartered in Indianapolis with an additional full- service site near Frankfurt, Germany. For more information about the company, please visit http://www.biostorage.com or call +1 (866) 697-2675 or +49 615 582 4490.


'/>"/>
SOURCE BioStorage Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioStorage Technologies Appoints Lori Ball as Vice President
2. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
3. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
4. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
5. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
6. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
7. NASA MidSTAR-1 successful technologies may be revolutionary
8. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
9. Neurobiological Technologies Sets Date for Research and Development Day
10. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc.
11. Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), ... for operable and inoperable solid tumor cancers, announced today ... of NW Bio, will present at the Phacilitate Immunotherapy ... Hyatt Regency Hotel in Miami, Florida ... entitled "New Therapeutic Approaches – Expanding the Reach of ...
(Date:1/18/2017)... January 18, 2017 According to a new market research ... Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) ... reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, growing ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... ... ... Executive search firm Slone Partners proudly supports the SCOPE ... of the clinical trials segment. Hosted in Miami, this conference brings together renowned ... , As executive talent specialists in the industries central to clinical trials, ...
(Date:1/18/2017)... ... 2017 , ... MYOLYN, which creates medical technology for people ... to the FDA, requesting clearance of the MyoCycle Home and the MyoCycle Pro ... , The submission marks a major milestone for the technology startup. MYOLYN spun ...
Breaking Biology Technology:
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017 /PRNewswire/ ... in performance biometric sensor technology, today announced the ... Benchmark™ sensor systems, the highly-accurate biometric sensor ... ® biometric technology, experience and expertise. The ... of Benchmark designed specifically for hearables, and Benchmark ...
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   ... data sensor technology, and STMicroelectronics (NYSE: ... spectrum of electronics applications, announced today the launch ... kit for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December 15, 2016 ... financial services provider, today announced an agreement with NuData Security, ... to join forces. The partnership will enable clients to focus ... compliance with local data protection regulation. ... In order to provide a ...
Breaking Biology News(10 mins):